FASENRA Regulatory Postmarketing Surveillance in Korea

Trial Identifier: D3250R00043
Sponsor: AstraZeneca
NCTID:: NCT05091333
Start Date: March 2022
Primary Completion Date: January 2025
Study Completion Date: January 2025
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations